JP2025501410A5 - - Google Patents

Info

Publication number
JP2025501410A5
JP2025501410A5 JP2024561730A JP2024561730A JP2025501410A5 JP 2025501410 A5 JP2025501410 A5 JP 2025501410A5 JP 2024561730 A JP2024561730 A JP 2024561730A JP 2024561730 A JP2024561730 A JP 2024561730A JP 2025501410 A5 JP2025501410 A5 JP 2025501410A5
Authority
JP
Japan
Prior art keywords
disorder
depression
compound
free form
anxiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561730A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501410A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/010050 external-priority patent/WO2023130117A1/en
Publication of JP2025501410A publication Critical patent/JP2025501410A/ja
Publication of JP2025501410A5 publication Critical patent/JP2025501410A5/ja
Pending legal-status Critical Current

Links

JP2024561730A 2022-01-03 2023-01-03 重水素化有機化合物およびその使用 Pending JP2025501410A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263296134P 2022-01-03 2022-01-03
US63/296,134 2022-01-03
US202263345007P 2022-05-23 2022-05-23
US63/345,007 2022-05-23
US202263384992P 2022-11-25 2022-11-25
US63/384,992 2022-11-25
PCT/US2023/010050 WO2023130117A1 (en) 2022-01-03 2023-01-03 Deuterated organic compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2025501410A JP2025501410A (ja) 2025-01-17
JP2025501410A5 true JP2025501410A5 (https=) 2026-01-15

Family

ID=87000368

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024561730A Pending JP2025501410A (ja) 2022-01-03 2023-01-03 重水素化有機化合物およびその使用

Country Status (10)

Country Link
US (1) US20250091990A1 (https=)
EP (1) EP4460490A4 (https=)
JP (1) JP2025501410A (https=)
KR (1) KR20240132476A (https=)
AU (1) AU2023204432A1 (https=)
CA (1) CA3242751A1 (https=)
IL (1) IL314019A (https=)
MX (1) MX2024008372A (https=)
TW (1) TW202340145A (https=)
WO (1) WO2023130117A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202333671A (zh) 2022-01-03 2023-09-01 美商恩格瑞爾療法公司 氘化有機化合物及其用途
TW202517609A (zh) 2023-07-02 2025-05-01 美商英格瑞治療公司 氘化有機化合物及其用途(二)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102373288B1 (ko) * 2013-12-03 2022-03-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CN104744333A (zh) * 2013-12-26 2015-07-01 张云 一种奈莫必利的生产方法

Similar Documents

Publication Publication Date Title
JP7278359B2 (ja) Shp2の活性を阻害するための化合物および組成物
JP2025501410A5 (https=)
JP2025501411A5 (https=)
EP3094627B1 (en) 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2
JP2009538853A5 (https=)
JP2023527575A5 (https=)
JP2020023528A5 (https=)
JP2021519267A5 (https=)
AU2016228207B2 (en) Sigma ligands for the prevention or treatment of pain induced by chemotherapy
RU2015143466A (ru) Нейроактивные стероиды и способы их применения
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
CN118576586A (zh) 治疗神经和精神疾病的方法
RU2009136330A (ru) Тетрагидроизохинолиновые соединения в качестве модуляторов гистаминового н3 рецептора
JP2022549335A5 (https=)
JP2019534327A5 (https=)
KR20180080305A (ko) 인돌린-2-온 유도체
JP2017526659A5 (https=)
JP2020511515A5 (https=)
JP2022513933A5 (https=)
JP2017523201A5 (https=)
US20180244623A1 (en) N-methyl-D-aspartate Receptor (NMDAR) Potentiators, Pharmaceutical Compositions, And Uses Related Thereto
RU2008148941A (ru) 4-[(3-фторфенокси)фенилметил]пиперидин метансульфонат, применение, способ синтеза и фармацевтические композиции
JP2025509886A (ja) サイクリン依存性キナーゼ2阻害剤としてのスルホンアミド誘導体
TWI677495B (zh) 吲哚啉-2-酮衍生物
JP2024511057A5 (https=)